Similar studies in mice implanted with MC38 B2m KO cells indicated abrogated tumor response to either immune checkpoint inhibitor, contrasting with a significant decrease in tumor growth observed in mice harboring MC38 wt tumors (Fig 5D and 5E). This evidence concerns the gene B2M and neoplasm.